UBS (CH) Equity Fd Swiss Hi Div CHF I-A1
Performance (in CHF)
Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.
Performance
1 month | -6.33% |
---|---|
Current year | 2.91% |
3 years p.a. | 3.94% |
5 years p.a. | 8.18% |
10 years p.a. | 7.25% |
Since inception p.a. | n.a. |
Rolling performance in %
Key figures
YTD | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Performance | 2.91% | 7.21% | 12.30% | 48.21% | 101.40% |
Maximum profit on monthly basis | 6.00% | 6.12% | 6.12% | 10.52% | 10.52% |
Maximum loss on monthly basis | -1.53% | -2.86% | -7.47% | -7.47% | -8.31% |
Max drawdown | -14.31% | -14.31% | -16.42% | -19.58% | -28.94% |
Volatility | 19.66% | 14.43% | 13.05% | 13.49% | 14.36% |
Sharpe ratio | 0.36 | 0.35 | 0.10 | 0.50 | 0.47 |
Maximum continuous profit in months | 2 | 2 | 5 | 7 | 7 |
Maximum continuous loss in months | 1 | 2 | 4 | 4 | 4 |
Positive months / profit duration in months | 3 | 7 | 21 | 38 | 74 |
Negative months / loss duration in months | 1 | 6 | 16 | 23 | 47 |
Master data
Fund name | UBS (CH) Equity Fd Swiss Hi Div CHF I-A1 |
---|---|
Fund management company | UBS Fund Management (Switzerland) AG |
Fund domicile | Switzerland |
Inception date | 09 January 2014 |
ISIN | CH0205552091 |
Swiss security no. | 20555209 |
Fund currency | CHF |
Appropriation of income | distributing |
Issuing commission | |
Ongoing charges under PRIIP KID as at 16 October 2024 | 0.64% |
End of financial year | 31 August |
Paying agent | UBS Switzerland AG |
Fund volume as at 31 March 2025 | 730.48 Mio. CHF |
Net asset value (NAV) as at 23 April 2025 | 183.93 CHF |
Portfolio structure
Top holdings of fund volume (in %)
Nestle | 10.09% | |
Novartis AG | 9.88% | |
Roche Hldg. Genußsch. | 9.75% | |
Zurich Insurance Group | 9.20% | |
UBS Group AG | 7.43% | |
Swiss Re AG | 6.66% | |
ABB Ltd.-Reg. | 5.99% | |
Givaudan | 4.40% | |
Holcim AG | 4.27% | |
Swiss Life | 3.47% |